Su LL - Search Results

1

Expression of Yes-associated protein in non-small cell lung cancer and its relationship with clinical pathological factors.

Su LL, Ma WX, Yuan JF, Shao Y, Xiao W, Jiang SJ. Su LL, et al. Chin Med J (Engl). 2012 Nov;125(22):4003-8. Chin Med J (Engl). 2012. PMID: 23158133

2

[The relationship between transforming growth factor-beta1, platelet derived growth factor and airway remodeling in eosinophilic bronchitis].

Li HC, Zhang J, Huang C, Wang MF, Jiang SJ, Mu XY, Lin DJ, Chi XY, Su LL, Zhu L, Zhang CQ. Li HC, et al. Among authors: su ll. Zhonghua Jie He He Hu Xi Za Zhi. 2003 Dec;26(12):761-4. Zhonghua Jie He He Hu Xi Za Zhi. 2003. PMID: 14720431 Chinese.

3

Diagnostic and therapeutic value of thoracoscopy for pleural effusions: experience from 628 consecutive cases in China.

Jiang SJ, Zhang S, Su LL, Liu Y. Jiang SJ, et al. Among authors: su ll. Chin Med J (Engl). 2009 May 20;122(10):1227-30. Chin Med J (Engl). 2009. PMID: 19493476 No abstract available.

4

[The diagnostic value of medical thoracoscopy for unexplained pleural effusion].

Jiang SJ, Mu XY, Zhang S, Su LL, Ma WX. Jiang SJ, et al. Among authors: su ll. Zhonghua Jie He He Hu Xi Za Zhi. 2013 May;36(5):337-40. Zhonghua Jie He He Hu Xi Za Zhi. 2013. PMID: 24047806 Chinese.

5

Liu Y, Liu Y, Su L, Jiang SJ. Liu Y, et al. PLoS One. 2014 Mar 21;9(3):e92773. doi: 10.1371/journal.pone.0092773. eCollection 2014. PLoS One. 2014. PMID: 24658073 Free PMC article. Review.

6

Identification of Gene Biomarkers for Distinguishing Small-Cell Lung Cancer from Non-Small-Cell Lung Cancer Using a Network-Based Approach.

Long F, Su JH, Liang B, Su LL, Jiang SJ. Long F, et al. Among authors: su ll, su jh. Biomed Res Int. 2015;2015:685303. doi: 10.1155/2015/685303. Epub 2015 Jul 28. Biomed Res Int. 2015. PMID: 26290870 Free PMC article.

7

Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis.

Liu Y, Su L, Jiang SJ, Qu H. Liu Y, et al. Oncotarget. 2017 Aug 4;8(35):59729-59739. doi: 10.18632/oncotarget.19927. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938676 Free PMC article.

8

Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review).

You W, Shang B, Sun J, Liu X, Su L, Jiang S. You W, et al. Oncol Rep. 2020 Aug;44(2):424-437. doi: 10.3892/or.2020.7643. Epub 2020 Jun 11. Oncol Rep. 2020. PMID: 32627031 Free PMC article. Review.

9

Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors.

Hu X, Wang L, Shang B, Wang J, Sun J, Liang B, Su L, You W, Jiang S. Hu X, et al. Front Immunol. 2023 Mar 6;14:1094414. doi: 10.3389/fimmu.2023.1094414. eCollection 2023. Front Immunol. 2023. PMID: 36949956 Free PMC article. Review.

10

Identifying optimal first-line immune checkpoint inhibitors based regiments for advanced non-small cell lung cancer without oncogenic driver mutations: A systematic review and network meta-analysis.

Liu T, Wu S, Fang W, Li H, Su L, Qi G, Li H, Liu Y. Liu T, et al. PLoS One. 2023 Apr 18;18(4):e0283719. doi: 10.1371/journal.pone.0283719. eCollection 2023. PLoS One. 2023. PMID: 37071610 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters